NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib

Ryujiro Hara, Makoto Onizuka, Erika Matsusita, Eri Kikkawa, Yoshihiko Nakamura, Hiromichi Matsushita, Daisuke Ohgiya, Hiromichi Murayama, Shinichiro Machida, Ken Ohmachi, Yukari Shirasugi, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

A recent study reported that treatment-free remission (TFR) of chronic myeloid leukemia (CML) after dasatinib (Das) treatment was significantly associated with natural killer (NK) cell proliferation in the peripheral blood. However, biomarkers to predict lymphocytosis or successful TFR are not well characterized. In order to clarify individual differences in NK cell responses among patients treated with Das, we retrospectively analyzed the association between polymorphisms in the natural killer group 2D receptor [NKG2D; also known as killer cell lectin like receptor K1 (KLRK1)] gene and clinical outcomes in 31 patients treated with Das as first-line treatment for CML. Patients with the NKG2D HNK1/HNK1 (high-cytotoxic activity-related allele on NKG2D hb-1) haplotype achieved MR4.5 more quickly than those with other haplotypes [hazard ratio (HR) 4.39; 95% confidence interval (CI) 2.75–118.6; P = 0.004]. In addition, NK cells with the NKG2D HNK1 allele exhibited enhanced phosphorylation of vav guanine nucleotide exchange factor 1 (VAV1) at Tyr174. These data suggest that NKG2D gene polymorphisms may represent candidate biomarkers for the prediction of TFR following Das treatment.

Original languageEnglish
Pages (from-to)666-674
Number of pages9
JournalInternational journal of hematology
Volume106
Issue number5
DOIs
Publication statusPublished - 2017 Nov 1
Externally publishedYes

Keywords

  • Chronic myeloid leukemia
  • Natural killer cell
  • Natural killer group 2D receptor
  • Single nucleotide polymorphism
  • Vav guanine nucleotide exchange factor 1

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib'. Together they form a unique fingerprint.

Cite this